Tourmaline Bio Inc. (TRML) — Cash Flow Quality Index
Latest as of December 2023:
5.18x
Tourmaline Bio Inc. (TRML) has a Cash Flow Quality Index of 5.18x as of December 2023. Operating cash flow of $11.02 Million exceeds net income of $2.13 Million, indicating high earnings quality where cash backs reported profits. Explore investment intensity of Tourmaline Bio Inc. to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
5.18x
Operating CF / Net Income
Operating Cash Flow
$11.02 Million
USD
Net Income
$2.13 Million
USD
Data as of
Dec 2023
Most recent filing
Annual Cash Flow Quality Index for Tourmaline Bio Inc. (None–None)
Year-by-year earnings quality comparison for Tourmaline Bio Inc.. For live market cap and the full company financial profile, see Tourmaline Bio Inc. (TRML) total market value.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.